1. Marchesini, Matteo, Gherli, Andrea, Simoncini, Elisa, Colla, Simona, Roti, Giovanni. 2024. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML. In Nature communications, 15, 4739. doi:10.1038/s41467-024-48953-3. https://pubmed.ncbi.nlm.nih.gov/38834613/
2. Kumar, Shashank, Shuaib, Mohd, AlAsmari, Abdullah F, Alqahtani, Faleh, Gupta, Sanjay. 2023. GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. In Cancers, 15, . doi:10.3390/cancers15102723. https://pubmed.ncbi.nlm.nih.gov/37345060/
3. Xu, Yan, Cai, Hongbing, Tu, Wei, Ding, Lingying, Luo, Rongcheng. . Increased PA2G4 Expression Is an Unfavorable Factor in Nasopharyngeal Carcinoma. In Applied immunohistochemistry & molecular morphology : AIMM, 29, 513-518. doi:10.1097/PAI.0000000000000918. https://pubmed.ncbi.nlm.nih.gov/33605574/
4. Massignam, Eloísa Toscan, Dieter, Cristine, Assmann, Taís Silveira, Canani, Luis Henrique, Crispim, Daisy. 2022. The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients. In Microvascular research, 143, 104378. doi:10.1016/j.mvr.2022.104378. https://pubmed.ncbi.nlm.nih.gov/35594935/
5. Kim, Dongha, Lee, Young Seok, Kim, Jin Ki, Kim, Sung Young. . Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis. In Critical reviews in eukaryotic gene expression, 29, 581-597. doi:10.1615/CritRevEukaryotGeneExpr.2019026317. https://pubmed.ncbi.nlm.nih.gov/32422012/
6. Neilson, Karen M, Abbruzzesse, Genevieve, Kenyon, Kristy, Alfandari, Dominique, Moody, Sally A. 2016. Pa2G4 is a novel Six1 co-factor that is required for neural crest and otic development. In Developmental biology, 421, 171-182. doi:10.1016/j.ydbio.2016.11.021. https://pubmed.ncbi.nlm.nih.gov/27940157/
7. Koach, Jessica, Holien, Jessica K, Massudi, Hassina, Cheung, Belamy B, Marshall, Glenn M. 2019. Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface. In Cancer research, 79, 5652-5667. doi:10.1158/0008-5472.CAN-19-1112. https://pubmed.ncbi.nlm.nih.gov/31501192/
8. Hou, Xiaofeng, Tang, Wenhai. 2020. Pseudogene PA2G4P4 promotes oncogene PA2G4 expression and nuclear translocation to affect glioblastoma cell viability and apoptosis. In Life sciences, 265, 118793. doi:10.1016/j.lfs.2020.118793. https://pubmed.ncbi.nlm.nih.gov/33220287/
9. Alan Harris, R, Archer, Kellie J, Goodarzi, Mark O, McAllister, Jan M, Strauss, Jerome F. 2022. Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome. In Gene, 852, 147062. doi:10.1016/j.gene.2022.147062. https://pubmed.ncbi.nlm.nih.gov/36423778/
10. He, Shi-Wei, Liang, Ye-Lin, Zhang, Yuan, Liu, Na, Li, Ying-Qing. 2023. LINC00173 facilitates tumor progression by stimulating RAB1B-mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. In Molecular oncology, 17, 518-533. doi:10.1002/1878-0261.13375. https://pubmed.ncbi.nlm.nih.gov/36606322/